Plain-English translation of NCT07349381 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a medication called CX11 to understand how food affects the way your body absorbs and processes it. Researchers want to know whether taking this medication with a meal changes how much of it enters your bloodstream compared to taking it on an empty stomach. This is an early-stage study in healthy volunteers to gather safety and absorption information.
For patients who will eventually take this medication, it's important to know whether they need to take it with or without food to get the best results. This foundational research helps doctors give clear instructions about how to use the treatment safely and effectively.
You likely qualify if…
You likely don't qualify if…
You would participate in two separate treatment cycles. In one cycle, you would take the medication after fasting (on an empty stomach); in the other cycle, you would take it after eating a meal. Blood samples would be collected at various time points to measure how much medication enters your bloodstream in each scenario. The study involves multiple visits over several weeks, with careful monitoring of your health throughout.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Phase
Safety & dosing
Sponsor
Vincentage Pharma Co., Ltd
Collaborators
Corxel Pharmaceuticals
Enrollment target
~32 participants
Started
March 2026
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Wang
Vincentage Pharma Co., Ltd
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.